Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?

Mehmet Sinan Dal1, Emre Tekgündüz1, Merih Kızıl Çakar1

  • 1Ankara Oncology Education and Research Hospital, Hematology and Stem Cell Transplantation Clinic, Ankara, Turkey.

Abstract

Insights

Microbial contamination in hematopoietic progenitor cell (HPC) grafts is low (1.3%) and using contaminated products for hematopoietic cell transplantation (HCT) appears safe, with no 30-day mortality observed. Further analysis indicates antibiotic prophylaxis may mitigate risks associated with contaminated HPC products.

Area of Science:

  • Hematology
  • Microbiology
  • Transplantation Science

Background:

  • Microbial contamination of hematopoietic progenitor cell (HPC) grafts can indicate process issues and impact transplantation outcomes.
  • Assessing contamination rates and their effect on hematopoietic cell transplantation (HCT) success is crucial for patient safety.

Purpose of the Study:

  • To determine the incidence of microbial contamination in HPC grafts.
  • To evaluate the safety and success of HCT in patients who received contaminated HPC products.

Main Methods:

  • Retrospective analysis of microbial contamination records for HPC grafts from 2012-2015.
  • Evaluation of contamination rates at multiple stages for autologous donors and pre-HCT for allogeneic donors.
  • Analysis of bacterial contamination in peripheral blood and bone marrow products.

Main Results:

  • Overall bacterial contamination rate in HPC grafts was 1.15% (18/1552 cultures).
  • Microbial contamination was detected in 1.3% (16/1212 samples) of grafts used for HCT in 248 patients.
  • Nine patients received contaminated products; 8 experienced febrile neutropenia, but none died within 30 days post-HCT.

Conclusions:

  • The use of contaminated HPC products, with antibiotic prophylaxis, did not lead to increased mortality within 30 days post-HCT.
  • Contaminated products did not adversely affect key engraftment parameters or hospitalization duration.
  • Findings suggest that HCT with contaminated products may be safe under specific conditions, warranting further investigation.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K